G6PD and malaria: Malaria patients with <30% of normal G6PD activity can receive primaquine with a dose adjustment (45 mg weekly dose for 8 weeks) under medical supervision [11], and tafenoquine is only prescribed to those with more than 70% G6PD activity [12].